Editorial

DOI: 10.4244/EIJ-E-23-00068

Acute changes in microvascular resistance after treating aortic stenosis

Nils P. Johnson1, MD, MS; Rob Eerdekens2, MD, MSc

How does the reversal of aortic stenosis by transcatheter aortic valve implantation (TAVI) acutely alter myocardial physiology? Addressing this question – as was done in the recent collaborative manuscript from three centres in Italy and Belgium1 – allows us a timely opportunity to synthesise 30 years of data with a view to clinical application.

Components of resistance

While often written about in the singular form, the term “hyperaemic microvascular (or myocardial) resistance” actually contains two conceptual parts. First, how much flow (mL/min) results from a given coronary driving pressure (mmHg)? Second, at what coronary pressure does flow cease? The first notion corresponds to our intuition of resistance (a constant value during hyperaemia). However, the second notion reminds us that – unlike a classical electrical circuit – the system does not behave proportionally without accounting for what has been termed the zero-flow or wedge or back pressure (depending on the details of its assessment and with conceptual differences beyond the scope of this editorial). Visually, myocardial resistance can be depicted as shown in Figure 1A: a straight line linking...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 5
Mar 4, 2024
Volume 20 Number 5
View full issue


Key metrics

On the same subject

Letter to the editor

10.4244/EIJ-D-22-00998 Mar 20, 2023
Letter: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?
Minten L et al
free

Clinical research

10.4244/EIJ-D-22-00817 Jun 19, 2023
Impact of early changes in cardiac damage following transcatheter aortic valve implantation
Zhou Y et al

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free

10.4244/EIJV14I11A209 Dec 7, 2018
PCI in TAVI patients: who, why and when?
Patterson T et al
free
Trending articles
338.13

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
295.45

Expert consensus

10.4244/EIJ-D-21-00898 Sep 20, 2022
Intravascular ultrasound guidance for lower extremity arterial and venous interventions
Secemsky E et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
149.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved